Severity of endogenous intoxication in tuberculosis/HIV co-infected patients with fi rst diagnosed pulmonary tuberculosis

被引:0
|
作者
Yasinskyi, R. M. [1 ]
机构
[1] Zaporizhzhia State Med Univ, Dept Phthisiol & Pulmonol, Zaporizhia, Ukraine
关键词
Tuberculosis; HIV; Endotoxins;
D O I
10.14739/2310-1210.2016.4.79692
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Biochemical parameters participation in systemic inflammatory response syndrome (SIRS) development at tuberculosis/HIV co-infection has not been carefully studied by now and severity of endogenous intoxication, as well as its influence on the disease occur. Aim. To determine the intensity of endogenous intoxication in tuberculosis/HIV co-infected patients with first diagnosed pulmonary tuberculosis (FDTB/HIV), depending on the severity of the disease. Materials and methods. 54 patients with FDTB/HIV were examined and divided into 3 groups. The 1st group included 15 patients without SIRS, with local tuberculosis, without massive bacterial excretion, with the number of CD4(+)-cells more than 200 in 1 ml, or if there was the only one of the next signs (disseminative destructive tuberculosis, massive bacterial excretion, the number of CD4(+)-cells less than 200 in 1 ml). The 2nd group included 13 patients who had more than one sign. The 3rd group consisted of 26 patients with SIRS. SIRS was diagnosed by R. Bone et al. (1992). As a markers of endogenous intoxication C-reactive protein (CRP), rheumatoid factor (RF), fibrin, seromucoid by standard methods; alpha 1-antitrypsin (alpha 1-AT) - by immunoassay kit Immundiagnostik, Germany; protein fractions were determined by electrophoresis; intermediate mass molecules (IMM) - by B. Halliwell method (1999) were measured. Results. In FDTB/HIV patients seromucoid, fibrin, alpha 1-AT, gamma-globulins and IMM levels were increased; albumin levels and albumin-globulin ratio were reduced independently of the process severity. The levels of CRP and RF were also increased if disease was severer. Dysproteinemia is compounded in the presence of SIRS and IMM levels 2-fold increase compared to control. Conclusion. This indicates that the levels of acute inflammation phase marks, protein fractions and IMM are dependent not only on the presence of pathogens in the organism, but also on the disease severity.
引用
收藏
页码:68 / 72
页数:5
相关论文
共 50 条
  • [21] Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy
    Basel Karo
    Gérard Krause
    Stefanie Castell
    Christian Kollan
    Osamah Hamouda
    Walter Haas
    BMC Infectious Diseases, 17
  • [22] Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy
    Karo, Basel
    Krause, Gerard
    Castell, Stefanie
    Kollan, Christian
    Hamouda, Osamah
    Haas, Walter
    BMC INFECTIOUS DISEASES, 2017, 17
  • [23] Safety and effectiveness of HAART in tuberculosis-HIV co-infected patients in Brazil
    dos Santos, A. P. G.
    Pacheco, A. G.
    Staviack, A.
    Golub, J. E.
    Chaisson, R. E.
    Rolla, V. C.
    Kritski, A. L.
    Passos, S. R. L.
    Mello, F. C. de Queiroz
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (02) : 192 - 197
  • [24] Tuberculosis treatment default among HIV-TB co-infected patients in urban Uganda
    Elbireer, Sawsan
    Guwatudde, David
    Mudiope, Peter
    Nabbuye-Sekandi, Juliet
    Manabe, Yukari C.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 (08) : 981 - 987
  • [25] Plasma Biomarkers of Risk of Tuberculosis Recurrence in HIV Co-Infected Patients From South Africa
    Pillay, Kimesha
    Lewis, Lara
    Rambaran, Santhuri
    Yende-Zuma, Nonhlanhla
    Archary, Derseree
    Gengiah, Santhanalakshmi
    Govender, Dhineshree
    Hassan-Moosa, Razia
    Samsunder, Natasha
    Abdool Karim, Salim S.
    McKinnon, Lyle R.
    Padayatchi, Nesri
    Naidoo, Kogieleum
    Sivro, Aida
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [26] Dynamics of tuberculosis in HIV-HCV co-infected cases
    Faniran, Taye Samuel
    Adewole, Matthew O.
    Ahmad, Hijaz
    Abdullah, Farah A.
    INTERNATIONAL JOURNAL OF BIOMATHEMATICS, 2023, 16 (03)
  • [27] Ocular Tuberculosis in Human Immunodeficiency Virus and Systemic Tuberculosis Co-infected Patients
    Jain, Sahil
    Bajgai, Priya
    Kaur, Savleen
    Dogra, Mohit
    Sharma, Aman
    Sharma, Kusum
    Katoch, Deeksha
    Dogra, Mangat R.
    Gupta, Vishali
    Singh, Ramandeep
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (05) : 1002 - 1006
  • [28] Treatment outcomes of patients co-infected with tuberculosis and HIV at Chiang Mai University Hospital, Thailand
    Limmahakhun, S.
    Chaiwarith, R.
    Nuntachit, N.
    Sirisanthana, T.
    Supparatpinyo, K.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2012, 23 (06) : 414 - 418
  • [29] Delayed HIV treatment, barriers in access to care and mortality in tuberculosis/HIV co-infected patients in Cali, Colombia
    Gonzalez-Duran, Jorge A.
    Plaza, Regina, V
    Luna, Lucy
    Arbelaez, Maria Patricia
    Deviaene, Meagan
    Keynan, Yoav
    Rueda, Zulma Vanessa
    Marin, Diana
    COLOMBIA MEDICA, 2021, 52 (04):
  • [30] Renal Manifestations in Children Co-Infected with HIV and Disseminated Tuberculosis
    Nourse, P.
    Cotton, M. F.
    Bates, W. D.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1826 - 1826